Is Gilead Sciences, Inc. a good dividend stock?

Gilead Sciences, Inc. (GILD) is a dividend-paying stock with a current dividend yield of 2.38%. Review its dividend history, payout consistency and growth to judge whether it fits your income strategy.

What is GILD's dividend yield?

The dividend yield for GILD stock is currently 2.38%.

How much does GILD pay in dividends per year?

Gilead Sciences, Inc. pays an annual dividend of $3.2200 per share over the trailing twelve months.

How often does GILD pay dividends?

GILD stock pays dividends quarterly.

Is GILD's dividend growing?

Gilead Sciences, Inc.'s 3-year dividend CAGR is 2.85%.

GILD Stock Price, Chart, Stats & News

Gilead Sciences, Inc.

Save

Overview Dividend safety Dividends Fundamentals

Gilead Sciences, Inc. (GILD) is a dividend-paying stock with a current dividend yield of 2.38% as of Aug 4, 2026. It pays $3.22 per share over the trailing twelve months and distributes quarterly. Its dividend has grown at a 2.98% 5-year compound annual rate.

167.92B

Market cap

–

Current P/E

15.22x

Forward P/E

2.38%

Dividend yield

$3.22

GILD dividend

Dividend safety

Moderate

Dividend coverage is moderate for GILD — worth a closer look at the full safety breakdown.

See the safety analysis

GILD chart

Loading chart...

Fundamentals

Gross margin	80.80%
Operating margin	37.37%
Pretax margin	33.28%
Net margin	28.90%
Effective tax rate	13.13%
ROA	14.42%
ROE	41.01%
D/E	1.09x
Interest coverage ratio	10.73x

All financials

GILD valuation

P/E	–
P/S	5.66x
P/B	7.37x
P/CF	16.64x
P/FCF	17.63x
P/OCF	16.64x
PEG	3.87x
EV multiple	11.60x

About

Health care

Sector

Drug Manufacturers - General

Industry

Gilead Sciences, Inc. is a global biopharmaceutical enterprise, with operations spanning the United States, Europe, and numerous international markets. Its core mission involves discovering, developing, and commercializing innovative medications to address critical health needs. The company's extensive product portfolio encompasses treatments for a variety of severe conditions.